A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Opinion Development |
---|---|
Submitter | United Kingdom |
Regulatory programme |
|
CLP Annex VI Index Number |
|
Classification
Harmonised classification at the time of the proposal |
|
---|---|
Proposed harmonised classification by the dossier submitter |
|
Hazard classes open for commenting | Carcinogenicity Mutagenicity Acute Toxicity [inhalation] Acute Toxicity [oral] STOT SE STOT RE Skin Sensitisation Hazards to the Aquatic Environment |
Proposed specific concentration limits by the dossier submitter | ATEoral = 88.5 mg/kg ATEinhal = 0.48mg/L |
Intention timeline
Date of intention | 2017-11-02 |
---|---|
Expected date of submission | 2018-07-31 |
Submitted for accordance check | 2018-07-24 |
Final submission date | 2018-11-13 |
Start of consultation | 2018-12-17 |
Deadline for commenting | 2019-03-01 |
Legal deadline for opinion adoption | 2020-05-14 |
Documents
CLH report |
|
---|---|
Annexes to the CLH Report |
|
Comments received |
|
Public consultations - received attachments |
|
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
Oct. 8, 2019
- Date of opinion: 2019-09-20
- Status: Opinion Development → Opinion Adopted
March 3, 2020
- Background document: https://echa.europa.eu/documents/10162/b8276a1b-1dcf-2d8b-e75d-22efb8ad2978
- Comments received: https://echa.europa.eu/documents/10162/6f0899d7-db52-d3e6-5c9b-21960ea4d0b7 → https://echa.europa.eu/documents/10162/88b28eea-e41b-8b35-f1d7-a70a82efd4c4
- RAC opinion: https://echa.europa.eu/documents/10162/5948b222-7b07-ab3e-b055-465bc63a1ebc
Dec. 10, 2021
- ATP number and date: ATP17 - (11/03/2021), 17/12/2022
- Link to ATP / File Title: Official Journal
- Link to ATP / Full Path: https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32021R0849&from=EN
This version
April 4, 2019
- CLH report: https://echa.europa.eu/documents/10162/132ae580-5cab-d667-6d5b-189a196264b4 → https://echa.europa.eu/documents/10162/f9372e20-d3e5-ac9f-aacd-e7a1028a8e40
- Regulatory programme: BPD → Active substance in Biocidal Products
- Regulatory programme: PPP → Active substance in Plant Protection Products
March 12, 2019
- Comments received: https://echa.europa.eu/documents/10162/6f0899d7-db52-d3e6-5c9b-21960ea4d0b7
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/2bd893d5-ca19-f130-629d-4d8ea01b9295
- Status: Public Consultation → Opinion Development
Feb. 18, 2019
- Regulatory programme: Active substance in Plant Protection Products (in the meaning of Directive 91/414/EEC)
- Regulatory programme: PPP
Dec. 20, 2018
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/b3e1ce44-05a6-da6d-4195-f4eafa267601
- CLH report: https://echa.europa.eu/documents/10162/132ae580-5cab-d667-6d5b-189a196264b4
- Deadline for commenting: 2019-03-01
- Final submission date: 2018-11-13
- Hazard classes open for commenting: Carcinogenicity Mutagenicity Acute Toxicity [inhalation] Acute Toxicity [oral] STOT SE STOT RE Skin Sensitisation Hazards to the Aquatic Environment
- Legal deadline for opinion adoption: 2020-05-14
- Proposed harmonised classification by the dossier submitter: Aquatic Acute 1, M-factor=1000 → Aquatic Acute 1, M-factor=10 000
- Proposed harmonised classification by the dossier submitter: Aquatic Chronic 1, M-factor=100 000 → Aquatic Chronic 1, M-factor=10 000
- Status: Submitted → Public Consultation
- Start of consultation: 2018-12-17
Oct. 16, 2018
- Regulatory programme: BPD
Oct. 12, 2018
- Name: esfenvalerate (ISO); (S)-α-cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyrate → esfenvalerate (ISO); (αS)-α-cyano-3-phenoxybenzyl (2S)-2-(4-chlorophenyl)-3-methylbutyrate
Add the related substance to your watchlist to monitor this regulatory record.